06:23 AM EDT, 10/23/2025 (MT Newswires) -- West Pharmaceutical Services ( WST ) reported Q3 non-GAAP earnings Thursday of $1.96 per diluted share, up from $1.85 a year earlier.

Analysts polled by FactSet expected $1.68.

Net sales for the quarter ended Sept. 30 was $804.6 million, up from $746.9 million a year earlier.

Analysts surveyed by FactSet expected $785.7 million.

The company increased its 2025 adjusted earnings guidance to $7.06 to $7.11 per share, up from $6.65 to $6.85. Analysts surveyed by FactSet expect $6.77.

Net sales guidance for the year was raised to a range of $3.06 billion to $3.07 billion, up from $3.04 billion to $3.06 billion, the company said. Analysts surveyed by FactSet expect $3.04 billion.

Shares of the company were up nearly 5.5% in recent Thursday premarket activity.